Asia Pacific Vascular Grafts Market Size study, by Product (Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts), By Raw Material (Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts), By Application (Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease) and Country Forecasts 2022-2032
Asia Pacific Vascular Grafts Market is valued approximately USD 370 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.86% over the forecast period 2024-2032. Vascular grafts are medical devices used in vascular surgery to repair or avoid sick or damaged blood vessels. They are basically surgically implanted artificial blood vessels designed to replace naturally occurring blood vessels that have become weak, clogged, or obstructed. Materials used to make vascular grafts include biological tissues (e.g., human or animal-derived), synthetic polymers (e.g., polyethylene terephthalate or Dacron), or a mix of the two. Arteriovenous (AV) access for dialysis, peripheral artery bypass surgery, Coronary Artery Bypass Grafting (CABG), and aneurysm treatment are used in a variety of vascular procedures that employ AV grafts. Vascular grafts are used in the treatment of disorders affecting blood circulation, including peripheral vascular illnesses and cardiovascular diseases. They help restore normal blood flow, alleviate symptoms, and improve overall patient outcomes. The increasing prevalence of cardiovascular diseases and related conditions is a key trend for the Asia Pacific Vascular Grafts Market during the estimated period of 2024-2032. This trend stipulates the demand for innovative graft solutions tailored to the region's unique healthcare needs.
The Asia-Pacific region is experiencing a significant increase in cardiovascular diseases such as coronary artery disease and peripheral artery disease, creating a higher demand for vascular grafts used in surgical interventions. As per the National Library of Medicine, India is recorded with the highest burdens of Cardiovascular Disease (CVD) globally. The total number of deaths from CVD in India is estimated to grows from 2.26 million (1990) to 4.77 million (2020). Thereby, the rising incidences of the cardiovascular disease among population is witnessing a high demand for vascular grafts, which augments the market growth across the region. Moreover, the region's aging population contributes to a higher prevalence of vascular conditions such as aortic aneurysms and arterial blockages, further fueling the demand for these grafts. Economic growth and increasing healthcare expenditure across Asia-Pacific are enhancing accessibility to advanced medical technologies, including vascular grafts, thus driving market expansion. Asia-Pacific countries such as India, Thailand, and Malaysia are becoming major destinations for medical tourism, attracting patients from around the world for surgeries that include vascular graft procedures, contributing to market growth. Furthermore, public awareness campaigns and screening programs for cardiovascular diseases are on the rise in the region, leading to early detection and treatment, including the use of vascular grafts during the estimated period. However, the risk of graft failures, along with the high cost of vascular graft procedures, is expected to hinder the growth of the Asia Pacific Vascular Grafts Market between 2022 and 2032. don
The key Countries considered for the Asia Pacific Vascular Grafts Market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China's Vascular Grafts Market holds a significant position in the region and is poised for further growth in the anticipated years. The market is experiencing rapid growth due to the growing elderly population is creating a significant market potential for vascular grafts, driven by the increasing occurrence of age-related illnesses, particularly vascular diseases. There is a rising need for advanced medical solutions such as vascular grafts to cater to their healthcare requirements with a considerable portion of aged people facing cardiovascular health challenges. Also, the increasing prevalence of Chronic Kidney Disease (CKD) is stipulating the market in China. Furthermore, the Chinese government is investing in public healthcare, expanding access to advanced procedures such as vascular graft surgery for the general people. As a result, more surgeries are expected to be carried out, which is boosting the need for vascular grafts over the anticipated years. Whereas, the market in India is expected to develop at the fastest rate over the forecast period.
Major market player included in this report are:Terumo Corporation
MicroPort Scientific Corporation
LifeTech Scientific Corporation
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below: By Product
Hemodialysis Access Grafts
Endovascular Stent Grafts
Coronary Artery By-Pass Grafts
Vascular Grafts for Aorta Disease
Peripheral Vascular Grafts
By Raw Material
Synthetic Vascular Grafts
Biological Vascular Grafts
Hybrid Vascular Grafts
By Application
Cardiac Aneurysm
Kidney Failure
Vascular Occlusion
Coronary Artery Disease
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Years considered for the study are as follows:Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.